Various professional organizations have issued recommendations on use of the PSA test to screen for prostate cancer in different age groups.
Using Medicare claims databases, we aimed to determine rates of PSA testing in the context of screening recommendations during 1999-2015 for US men age ≥65, stratified by age group and census regions, after excluding claims relating to all prostate-related conditions.